Evidence map›Paper›PMID 34872064›Full record

Trial reportThe American journal of tropical medicine and hygiene2021

Cognitive Outcomes at 18 Months: Findings from the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) Trial.

Tarina Parpia, Erling Svensen, Sarah Elwood, Anne Wanjuhi, Ladislaus Blacy, Eliwaza Bayo, Eric Houpt, Elizabeth Rogawski McQuade, Mark DeBoer, James Platts-Mills and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of tropical medicine and hygiene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tarina ParpiaUniversity of Virginia Division of Infectious Diseases and International Health, Charlottesville, Virginia.
Erling SvensenHaukeland University Hospital, Bergen, Norway.
Sarah ElwoodUniversity of Virginia Division of Infectious Diseases and International Health, Charlottesville, Virginia.
Anne WanjuhiUniversity of Virginia Division of Infectious Diseases and International Health, Charlottesville, Virginia.
Ladislaus BlacyHaydom Global Health Research Centre, Haydom Lutheran Hospital, Haydom, Tanzania.
Eliwaza BayoHaydom Global Health Research Centre, Haydom Lutheran Hospital, Haydom, Tanzania.
Eric HouptUniversity of Virginia Division of Infectious Diseases and International Health, Charlottesville, Virginia.
Elizabeth Rogawski McQuadeUniversity of Virginia Division of Infectious Diseases and International Health, Charlottesville, Virginia.
Mark DeBoerDepartment of Pediatrics, University of Virginia, Charlottesville, Virginia.
James Platts-MillsUniversity of Virginia Division of Infectious Diseases and International Health, Charlottesville, Virginia.
Estomih MdumaHaydom Global Health Research Centre, Haydom Lutheran Hospital, Haydom, Tanzania.
Rebecca ScharfUniversity of Virginia Division of Infectious Diseases and International Health, Charlottesville, Virginia.

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
NIAID NIH HHS T32 AI007046
6 · The paper itself

Abstract

Micronutrient deficiencies and enteric infections negatively impact child growth and development. We enrolled children shortly after birth in a randomized, placebo-controlled, 2 × 2 factorial interventional trial in Haydom, Tanzania, to assess nicotinamide and/or antimicrobials (azithromycin and nitazoxanide) effect on length at 18 months of age. Cognitive score at 18 months using the Malawi Developmental Assessment Tool (MDAT), which includes gross motor, fine motor, language, and social assessments, was a secondary outcome. Here, we present the MDAT results of 1,032 children. There was no effect of nicotinamide (change in development-for-age Z score [DAZ] -0.08; 95% CI: -0.16, 0) or antimicrobials (change in DAZ 0.04; 95% CI: -0.06, 0.13) on overall MDAT score. The interventions had no effect on cognitive outcomes in subgroups defined by gender, socioeconomic status, birthweight, and birth season or on MDAT subscores. Further analyses are needed to identify targetable risk factors for impaired cognitive development in these settings.

Indexed as

Cognitive AgingEarly Intervention, EducationalAnti-Infective AgentsAntiparasitic AgentsAzithromycinChild DevelopmentCohort StudiesFemaleHumansInfantMaleNiacinamideNitro CompoundsSeasonsTanzaniaThiazolesAnti-Infective AgentsAntiparasitic AgentsAzithromycinNiacinamidenitazoxanideNitro CompoundsThiazolesVitamin B Complex

Identifiers

PMID34872064
PMCPMC8832914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.